Abstract Nasal swabs of 423 healthy humans who showed different levels of contact with animals (frequent, 168; sporadic, 94; no contact, 161) were obtained in Tunisia (2008Tunisia ( -2009, and 99 of them presented other associated risk factors. Methicillin-resistant Staphylococcus aureus (MRSA) was detected in one of these 423 samples (0.24%), retrieved from a veterinarian. The MRSA isolate was mecA-positive, typed as ST80-t203-SCCmecIVcagrIII, and contained tet(K), ant(6)-Ia, and aph(3′)-IIIa genes encoding tetracycline, streptomycin, and kanamycin resistance, respectively. This MRSA isolate also contained the lukF/lukS virulence gene encoding Panton-Valentine leukocidin. Fifty-four (12.8%) additional nasal samples contained methicillin-susceptible S. aureus (MSSA) and one isolate/sample was characterized. A high diversity of spa types (n=43; 4 new) and pulsed-field gel electrophoresis (PFGE) types (n=37) was detected among the 55 recovered S. aureus strains. The percentages of antimicrobial resistance/detected resistance genes were as follows: 
Introduction
Nosocomial infections caused by Staphylococcus aureus constitute an important health problem worldwide. This microorganism is usually associated with skin and soft tissue infections. However, it is also able to cause serious diseases, such as pneumonia, meningitis, or septicemia. Additionally, the pathogenicity of S. aureus infections is facilitated by the expression of several virulence factors, which include cell wall-associated adhesins and several toxin groups [1, 2] .
Of particular concern is methicillin-resistant S. aureus (MRSA), which has become a major threat due to an increasing incidence since its first report in 1961. First MRSA infections were facilitated by several predisposing factors, including recent hospitalization, admission to an intensive care unit (ICU), prolonged antibacterial therapy, or surgery. MRSA strains acquired in these environments are known as hospital-acquired MRSA (HA-MRSA) [3] . The presence of multiple antimicrobial resistance in S. aureus isolates, a common trait among HA-MRSA strains, is an important clinical problem limiting the therapeutic options [4] .
The first cases of MRSA in the community setting were reported in the early 1990s from patients without the aforementioned risk factors. These strains are well known as community-acquired MRSA (CA-MRSA) [5] . Currently, CA-MRSA infections occur among healthy people without risk factors for HA-MRSA acquisition, being reported at an increasing frequency having a worldwide distribution. These infections seem to be caused by isolates that differ from typical HA-MRSA by their genetic background, epidemiology, clinical spectrum, antibacterial resistance, and by the presence of determined toxin genes [6] . For example, CA-MRSA isolates are more likely than HA-MRSA isolates to encode putative virulence factors, such as Panton-Valentine leukocidin (PVL), a cytotoxic virulence factor that has been associated with severe pneumonia and with skin and soft tissue infections [6] [7] [8] . In the last several years, a livestock-associated genetic lineage of MRSA of the sequence type ST398 has emerged in farm animals, especially in pigs, and human infections due to this specific type of MRSA have also been reported [9] [10] [11] .
So far, few data exist about the prevalence of MRSA in nasal samples of the healthy population or about the genetic lineages of S. aureus that colonize the nares of healthy humans. A previous study carried out in the USA reported a MRSA carriage rate in healthy humans of about 0.84% [12] . Another study carried out in the Netherlands among healthcare workers with and without exposure to livestock detected MRSA carriage rates of 1.7% and 0.15%, respectively [13] . It is known that the nasal carriage of S. aureus has been identified as a risk factor for the development of infections at the hospital level, and if the microorganism is methicillin-resistant, it can cause serious health problems. Few studies have focused on which individuals are most likely to be colonized with S. aureus and which are most likely to specifically have MRSA. Likewise, little is known on the potential influence of animal contact for the acquisition of animal-and nonanimal-associated S. aureus strains.
Therefore, the present study was undertaken to determine the nasal carriage of MRSA and S. aureus in healthy individuals in order to identify whether the intensity of animal contact might be a risk factor for the acquisition of MRSA or other specific types of S. aureus strains. Likewise, we aimed to determine the characteristics of the obtained strains using different molecular techniques, including its clonal diversity.
Materials and methods

Study design and sampling
Nasal swabs of 423 healthy individuals were obtained in different regions of Tunisia from October 2008 to February 2009. Each of the individuals was asked to provide information about the level of contact with farm or companion animals (frequent, sporadic, or no contact) and also about the use of antimicrobials or contact with hospitalized patients during the three months prior to the sample time.
Microbiological isolation
All swabs were incubated in Tryptone Soy Broth (TSB) for 48 h and then the broths were subcultured on Oxacillin Resistance Screening Agar Base (ORSAB) medium (Oxoid, UK) for 24-48 h. S. aureus-compatible colonies were initially identified by conventional methods (Gram staining, catalase test, oxidase test and DNase production, and ability to coagulate rabbit plasma [BioRad, France]). Species identification was then confirmed by speciesspecific polymerase chain reaction (PCR) amplification of the nuc and spa genes [14] .
Antimicrobial susceptibility testing Susceptibility to 17 antimicrobial agents was performed using the disk diffusion method in accordance with the Clinical and Laboratory Standards Institute (CLSI) recommendations [15] . The antimicrobial agents tested were (charge in μg): oxacillin (1), cefoxitin (30) , kanamycin (30) , gentamicin (10), tobramycin (10), tetracycline (30) , chloramphenicol (30) , trimethoprim-sulfamethoxazole (1.25/23.75), erythromycin (15) , clindamycin (2), amikacin (30) , ciprofloxacin (5), mupirocin (5), vancomycin (30) , teicoplanin (30) , and penicillin and streptomycin (10 units). The double-disk diffusion test (D-test) with erythromycin and clindamycin disks was implemented in all isolates to detect inducible clindamycin resistance. Minimum inhibitory concentrations (MICs) for vancomycin and teicoplanin were performed by the agar dilution method [15] . S. aureus ATCC 25923 and ATCC 29213 and Enterococcus faecalis ATCC 29212 were used as the control strains.
Detection of the mecA gene and SCCmec typing
The presence of the mecA gene was studied by PCR in all oxacillin-and/or cefoxitin-resistant isolates, as previously described [16] . The SCCmec typing was performed for mecA-positive isolates by a multiplex PCR strategy, as previously described [17] .
Detection of antimicrobial resistance genes
The ribosomal methylases encoded by erm(A), erm(B), and erm(C) genes, which confer resistance to erythromycin and clindamycin, and the efflux pump encoded by the msr(A) gene, conferring resistance to erythromycin, were studied by PCR in erythromycin-resistant isolates [18, 19] . In addition, tet(K), tet(M), and tet(L) genes, conferring resistance to tetracycline, and aac(6′)-Ie-aph(2″)-Ia, aph (3′)-IIIa, and ant(6)-Ia genes, conferring resistance to gentamicin, kanamycin, and streptomycin, respectively, were amplified by PCR in all aminoglycoside-resistant S. aureus isolates [20, 21] . The presence of genes associated with resistance to trimethoprim-sulfamethoxazole (dfrA and dfrD) and chloramphenicol [cat(pC194), cat(pC221), and cat(pC223)] were analyzed by PCR as previously reported [22] .
Pulsed-field gel electrophoresis (PFGE) All S. aureus isolates were characterized by PFGE with SmaI restriction enzyme digestion as previously described [23] . The samples were run on 1% agarose gel in 0.5% TBE buffer at 14°C on a CHEF-DR II PFGE system by using an initial switching time of 5 s, which was increased to 40 s over 20 h at 6 V/cm. The DNA fingerprints generated by PFGE were analyzed with the manual method according to previously proposed criteria [24] and the digitalized method by Gel-Pro version 3.1 software. The obtained results were submitted to the MultiVariate Statistical Package (MVSP) software, generating dendrograms according to a simple matching coefficient and the unweighted pair group method with arithmetic mean (UPGMA) algorithm.
Other molecular typing methods of S. aureus isolates spa typing was performed in all S. aureus isolates as described elsewhere [25] . The X region of the spa gene was amplified by PCR, and sequences were analyzed using Ridom StaphType software version 1.5.21 (Ridom GmbH), which automatically detects spa repeats and assigns an spa type according to http://spaserver.ridom.de/.
Identification of the agr allele group (I-IV) was determined by multiplex PCR. The nucleotide sequence of each primer and the amplification conditions were as described earlier [26] .
Multilocus sequence typing (MLST) was performed in selected S. aureus isolates (those containing the genes of the PVL and those presenting new spa types) as described previously [27] . The allelic profile of each strain was obtained by sequencing internal fragments of seven unlinked housekeeping genes (arcC, aroE, glpF, gmk, pta, tpi, and yqiL). Alleles of the seven genes defined the allelic profile, which corresponded to a sequence type (ST) assigned by the MLST database (http://www.mlst.net).
Detection of staphylococcal toxin genes
All isolates were tested by PCR for the presence of four staphylococcal toxin genes [28] . The targeted genes were as follows: lukS-lukF encoding the PVL toxin, eta and etb encoding exfoliative toxins ETA and ETB, respectively, and tst encoding the toxic shock syndrome toxin (TSST). Table 1 shows the characteristics of the 423 individuals tested in relation to the level of contact with animals and other risk factors. Individuals included in the study were classified into four groups: (1) frequent contact with farm animals (veterinarians, veterinary students, farmers, and abattoir workers) (n=111); (2) high contact with companion animals (n=57); (3) sporadic contact with animals (n=94); (4) no contact with animals (n=161). Ninety-nine of these individuals had other risk factors, such as previous contact with hospitalized patients or the use of antibiotics in the three months prior to sampling.
Results
Carriage of MRSA and typing of isolates
The nasal swabs of all 423 individuals tested were analyzed for MRSA recovery and only one contained an mecApositive MRSA isolate, representing 0.24% of the total number of tested samples. This MRSA isolate (C2444) was recovered from a veterinarian and showed a phenotype of resistance that included, in addition to beta-lactams, resistance to tetracycline, streptomycin, and kanamycin, and harbored the tet(K), ant(6)-Ia, and aph(3′)-IIIa genes. MRSA strain C2444 was typed as SCCmec type IVc, and was ascribed to the agr type III, to the spa type t203, and to the MLST type ST80. It is interesting to remark that the genes encoding the PVL toxin were identified in this strain, but not the other tested toxin genes (tst, eta, and etb).
Detection of S. aureus and characterization of antimicrobial resistance mechanisms and virulence genes S. aureus was recovered in 55 of the 423 nasal samples tested and one isolate per sample was maintained for further studies. The origin of the 55 S. aureus isolates and their antimicrobial resistance patterns are shown in Table 2 . All isolates exhibited penicillin resistance, although only one of them showed oxacillin and cefoxitin resistance by the disk diffusion test and the mecA gene was identified in this isolate (MRSA C2444, recovered from the veterinarian previously indicated). Seventeen additional S. aureus isolates exhibited resistance to oxacillin but not to cefoxitin, and all of them were negative for the mecA gene. The remaining 37 S. aureus isolates showed oxacillin susceptibility, even though they were recovered in ORSAB medium.
All 55 S. aureus isolates showed susceptibility to vancomycin, teicoplanin, gentamicin, tobramycin, clinda-mycin, and mupirocin, showing MICs for vancomycin and teicoplanin of ≤1 μg/ml. Variable resistance rates were observed for tetracycline (21.8%), ciprofloxacin (16.4%), streptomycin (10.9%), kanamycin (7.3%), erythromycin and amikacin (5.4% each), and trimethoprim-sulfamethoxazole and chloramphenicol (1.8% each). No inducible clindamycin resistance was identified in the three erythromycin-resistant S. aureus isolates when the doubledisk erythromycin-clindamycin screening test was used.
The tst gene, encoding the toxic shock syndrome toxin, was detected in 11 of 55 isolates (20%). Other toxin genes detected included the lukS-lukF genes encoding the PVL toxin detected in four of the 55 studied S. aureus isolates (7.3%), and the eta and etb genes, encoding the exfoliative ETA and ETB toxins, respectively, harbored by two isolates. All four S. aureus isolates carrying the genes of PVL toxin were obtained from individuals with high contact with animals (n=3) or with sporadic contact with animals (n=1), but no PVL-positive isolate was identified in the group of individuals with no contact with animals. It is important to note that isolate C2431 is characterized by a high virulence potential, since it produced both exfoliative toxin ETA and ETB, and it was recovered from an individual that had taken antimicrobial agents in the several months prior to the study and who also had contact with hospitalized patients and with animals.
No correlation was found between the presence of virulence genes and antimicrobial resistance. It is important to note that, in our study, almost half of the S. aureus isolates obtained from individuals that reported high contact with farm or companion animals harbored genes encoding virulence factors, but only 13% of the isolates of individuals with no contact with animals presented this characteristic.
Molecular typing of S. aureus isolates and the detection of virulence genes All 55 S. aureus isolates were submitted to molecular typing by spa, agr, and PFGE techniques, and some selected S. aureus isolates were also submitted to MLST typing; the results are shown in Table 2 .
Analysis of SmaI macrorestriction profiles revealed a high clonal diversity with 37 unique PFGE patterns (Fig. 1) . These patterns were classified from S1 to S37, each defining a clone in accordance to the previously reported interpretive criteria [24] . The pulsotype S34 was the most frequently encountered pattern (7.3% of isolates, four isolates). Two isolates with S6 pulsotype produced exfoliative toxins (ETA and/or ETB). Four of 11 isolates harbored the tst gene and belonged to pulsotype S2. The four PVL-producing S. aureus isolates were ascribed to four different pulsotypes (S4, S19, S23, and S25).
Among the highly diverse spa gene types (n=43), four as yet undescribed types were identified (t6222, t6223, t6224, and t6225). spa typing analysis results confirmed those previously found in the analysis by PFGE: (1) isolates C2410 and C2425 belonging to pulsotype S35 presented the same spa type t166; (2) two isolates which shared the same t024 spa type belonged to pulsotype S5 (C2447 and C2442); (3) two isolates with identical pulsotype S7 (C2440 and C2432) shared the common spa type t084. There was no clear association between the spa type and the antimicrobial resistance pattern.
Amplification of the hypervariable region of the agr locus showed that agr group I was predominant (detected in 21 of 55 S. aureus isolates, 38.2%), followed by agr groups II and III (20% each), and agr group IV (1.8%). However, 11 isolates were untypable (20%). C2455  t012  S3  III  TSST-1  PE-CIP  C2456  t012  S2b  III  TSST-1  PE-OX  C2451  t018  S3  III  TSST-1  PE-CP  C2421  t725  S14  NT  TSST-1  PE-TE  C2412  t040  S8b  I  PE  C2415  t127  S13  III  PE-CL  C2408  t537  S10  I  PE  C2409   c   t254  S11  II  PE C2429  t002  S1  II  PE  C2413  t008  S1  I  PE  C2446  t094  S34  II  PE  C2416  t279  S34  NT  PE  C2407 t127 S1 II PE-OX All four PVL-positive S. aureus isolates and the four isolates presenting new spa types were analyzed by MLST and they were compared with the S. aureus MLST database. All eight S. aureus isolates belonged to seven different already known STs, and a new sequence type, ST1704, was also identified for S. aureus C2459 that presented the new spa type t6225 (Table 1) .
PFGE revealed remarkable clonality among isolates producing the virulence factor TSST-1, and also among those producing exfoliatin A and B. However, no clonal relationship has been detected among the four isolates in which the genes of the PVL toxin have been demonstrated (Fig. 1) .
Discussion
The rate of MRSA nasal carriage seems to be very low in healthy individuals in Tunisia, as only one person out of 423 tested was positive for MRSA (0.24%), although the initial number of positive cultures on the selective ORSAB medium suggested a much higher prevalence. It is interesting to remark that the MRSA-positive person was a veterinarian who worked with farm animals, and if we consider only the group of individuals with high contact with farm animals, the rate of nasal carriage is a little higher (one out of 111, 0.9%). Studies performed in other countries also show low nasal carriage of MRSA among the healthy population [29] , although this prevalence seems to be higher among people in contact with farm animals [30, 31] . It is interesting to point out that the MRSA strain recovered in our study presented a multi-resistant antimicrobial phenotype that included not only beta-lactams, but also aminoglycosides and tetracycline. Molecular typing revealed that MRSA strain C2444 belonged to ST80 and was characterized by cassette SCCmec type IVc, agr type III, and with PVL toxin production. All of these characteristics are in line with those of the major PVL-positive CA-MRSA clone detected in many European countries. Today, the ST80 PVL-positive CA-MRSA clone is disseminated in Asia, Europe, and the Middle East [32] . However, the spa type related to the MRSA isolate in our study was t203, which remains different from that of the European clone ST80, which is normally of spa type t044 [32, 33] . Nevertheless, both spa types are very similar, with the spa type t203 presenting an extra repeat (r12). The agr III/ST80 lineage detected in our study in MRSA strain C2444 has also been reported as one of the predominant lineages of PVL-positive methicillin-susceptible S. aureus (MSSA) [34, 35] . PVL production is considered as a common trait among CA-MRSA, but it is important to recognize that PVL-negative strains can also occur.
In this study, it has been detected that all of the PVLpositive S. aureus isolates were recovered in individuals that had contact with animals, but not among those without contact with animals. It is interesting to remark that these strains (the MRSA strain mentioned above as well as the three MSSA strains) were not clonally related and they presented different spa, PFGE, and MLST types, indicating no clonal relationship among them. The association of PVL production with ST30, ST121, or ST22 lineages in three of our MSSA strains has been previously identified as some of the most prevalent lineages of PVL-positive MSSA in different countries [34] [35] [36] . Moreover, sequence type ST30 constitutes one of the predominant CA-MRSA clones in Australian and South American isolates [37] . Nevertheless, the ST121 lineage may have a global distribution and it is more frequently associated to MSSA [36] , although it has also been recently detected in cases of CA-MRSA [38] . PVL-encoding genes had been detected in strains representing the majority of agr groups (I, III, and IV) and belonging to widely distributed STs [34] . The observed diversity of PVL-positive strains might be attributed to the fact that PVL genes are localized on phages, which facilitate the spread of PVL genes through S. aureus populations [39] .
Remarkably, the chromogenic medium intended for selective MRSA recovery also allowed the recovery of oxacillin-susceptible S. aureus isolates in some of the nasal samples. It is of interest to remark on the low specificity of this media for MRSA recovery, as previously reported by other authors [40] , as well as the importance of further characterizing isolates grown in this media with the appearance of MRSA.
A high clonal diversity was identified among the 55 S. aureus isolates obtained in this study (54 MSSA and one MRSA), reflected by 43 different spa types and 37 different PFGE patterns. In addition, eight different STs were identified by MLST among eight selected S. aureus isolates (four isolates PVL-positive and four isolates with new spa types). Seventeen S. aureus isolates among the 55 recovered in this study (30.9%) showed oxacillin resistance but cefoxitin susceptibility and did not carry the mecA gene; the presence of other mechanisms of resistance cannot be discarded in these mecA-negative strains, as it is the case of hyperproduction of penicillinase or modification of other penicillin-binding proteins [41] .
Besides the PVL-encoding genes, three other toxin genes were detected among S. aureus strains: tst (11 isolates), eta (two isolates), and etb (one isolate). This finding might have implications in human health.
Previous investigations reported that the agr groups of S. aureus were associated with the patterns of S. aureus diseases [28] . They reported that isolates of agr group I and II caused, preferentially, diseases mediated by enterotoxin and that agr group III isolates were involved in TSST-1-mediated diseases. In our study, a strong relationship was observed between agr group III and toxic shock syndrome toxin TSST-1. Similarly, we also noted that two isolates among the four harboring lukS-lukF genes belonged to the same agr group III.
This study is the first that reports both the rate of nasal carriage by MRSA and the nasal carriage of PVL-positive or TSST-positive S. aureus in healthy humans, not only in Tunisia, but also on the African continent. In this study, MRSA and PVL-positive S. aureus isolates (both MRSA and MSSA) were detected mostly among individuals in contact with animals. More studies should be performed in the future, including a greater number of individuals with different risk factors, in order to assess the risk of contact with animals in relation to the possibility of being a nasal carrier of this specific microorganism, as well as the risk for acquisition of staphylococcal infections.
